Scientia Advisors in the News

---

Publications

---

Press Releases

---

Events

---

Luminary Insights

---

Media Contact

---

Scientia Advisors in the News

GenomeWeb quotes Harry Glorikian in "Healthlinx Launches OvPlex in UK, Heating Up Race to Get Ovarian Cancer Dx to Market"

Tony Fong
March 18th, 2010

Australian biomarker and diagnostic firm Healthlinx last month launched its OvPlex test in the UK, the world's first protein-based ovarian cancer diagnostic to be commercially available.

"We know there will be quite a bit of new products entering the market. That will affect the strategy of many companies as competition heats up, pricing is affected, and go-to-market plans get adjusted."

Read the full article at GenomeWeb